Skip to main content
. 2022 Feb 21;13:817715. doi: 10.3389/fphar.2022.817715

FIGURE 1.

FIGURE 1

(A) The three-dimensional (3D) interaction diagram of the binding site of SARS-CoV-2 PLpro (PDB ID: 7CMD) with GRL0617. The active-site residues and GRL0617 are shown in stick form. The hydrogen-bond network with residues is indicated by red dotted lines. (B) 2D interaction diagram of the binding site of SARS-CoV-2 PLpro with GRL0617. (C) The generated 3D pharmacophore model at the active site of PLpro. (D) Closeup stereo view of the pharmacophore model. Pharmacophore features are color-coded: green, two aromatic features (F1 and F4); cyan, one hydrogen-bond acceptor feature (F2); purple, one hydrogen-bond donor feature (F3).